Table 1.
Systemic disease | Cystic fibrosis, Crohns disease, rheumatoid arthritis, hemolytic‐uremic syndrome, diabetes mellitus, systemic lupus erythematous, etc. |
Abdominal trauma | Bicycle/car‐accidents, child abuse, sports injuries |
Biliary disease | Gallstones, sludge, choledochuscysts, cholangitis |
Structural | Pancreas divisum/annulare, common channel syndrome, residual condition after duodenal and pancreatic surgery, duodenal diverticulum, and duodenal duplication |
Infections | EBV, Enterovirus, Salmonella, Mononucleosis, Mumps, Mycoplasma, Kawasaki, Coxsackie, Ascaris, Candida, etc. |
Medications | L‐Asparaginase, 6‐mercaptopurine, pentamidine, valproic acid, furosemid, 5‐ASA/Salazopyrin, tetracyklins, prednisone, etc. |
Metabolic | Hypertriglyceridemia, hypercalcemia, alfa 1‐antitrypsinbrist, diabetic ketoacidosis, etc. |
Genetic (hereditary) | PRSS‐1‐, SPINK‐1‐, CFTR‐, and CFTR‐mutations |
Autoimmune pancreatitis | |
Idiopathic | In some studies up to a third of pediatric patients no cause is determined |
Others | Transplantation particularly liver and bone marrow, post‐ERCP and pancreatic, tumors (ex pseudocysts, pancreatoblastoma, and solid pseudopapillary tumor) |
EBV, Epstein–Barr virus; 5‐ASA, 5‐aminosalicylic acid; SPINK‐1, serine protease inhibitor, Kazal type‐1; CFTR, cystic fibrosis transmembrane conductance regulator; ERCP, endoscopic retrograde cholangiopancreatography.